{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:21:29Z","timestamp":1784056889510,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U01TR002487"],"award-info":[{"award-number":["U01TR002487"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR002319"],"award-info":[{"award-number":["UL1 TR002319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jtct.2023.03.022","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:56:27Z","timestamp":1679630187000},"page":"356.e1-356.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-1590","authenticated-orcid":false,"given":"Anurekha G.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-1594","authenticated-orcid":false,"given":"Lena E.","family":"Winestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7781-2918","authenticated-orcid":false,"given":"Adam J.","family":"Lamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paibel","family":"Aguayo-Hiraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Baez Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-6527","authenticated-orcid":false,"given":"Tumaini R.","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dornsife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4187-8456","authenticated-orcid":false,"given":"Amy K.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-9165","authenticated-orcid":false,"given":"Julie R.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-9615","authenticated-orcid":false,"given":"Anurag K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.03.022_bib0001","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.022_bib0002","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MOH.0000000000000685","article-title":"Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia","volume":"28","author":"Qayed","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.022_bib0004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.20.03585","article-title":"Disease burden affects outcomes in pediatric and young adult B-cell lymphoblastic leukemia after commercial tisagenlecleucel: a Pediatric Real-World Chimeric Antigen Receptor Consortium Report","volume":"40","author":"Schultz","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0005","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.290.15.2008","article-title":"Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia","volume":"290","author":"Kadan-Lottick","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.03.022_bib0006","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.022_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26871","article-title":"An investigation of toxicities and survival in Hispanic children and adolescents with ALL: results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001","volume":"65","author":"Kahn","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.2000.18.4.813","article-title":"Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study","volume":"18","author":"Pollock","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0009","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2002-02-0395","article-title":"Racial and ethnic differences in survival of children with acute lymphoblastic leukemia","volume":"100","author":"Bhatia","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.022_bib0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/cam4.2739","article-title":"Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas","volume":"9","author":"Penumarthy","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtct.2023.03.022_bib0011","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/djaa107","article-title":"Poverty and targeted immunotherapy: survival in Children's Oncology Group clinical trials for high-risk neuroblastoma","volume":"113","author":"Bona","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2023.03.022_bib0012","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/pbc.25928","article-title":"Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010)","volume":"63","author":"Bona","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0013","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.2020006252","article-title":"Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis","volume":"137","author":"Bona","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.022_bib0014","doi-asserted-by":"crossref","first-page":"e29127","DOI":"10.1002\/pbc.29127","article-title":"Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy","volume":"68","author":"Zheng","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0015","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1002\/cncr.31560","article-title":"Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?","volume":"124","author":"Kehm","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0016","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1080\/10428194.2019.1574002","article-title":"Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment","volume":"60","author":"Winestone","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2023.03.022_bib0017","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/pbc.25472","article-title":"Participation in pediatric oncology research protocols: racial\/ethnic, language and age-based disparities","volume":"62","author":"Aristizabal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0018","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","article-title":"Traveling towards disease: transportation barriers to health care access","volume":"38","author":"Syed","year":"2013","journal-title":"J Community Health"},{"key":"10.1016\/j.jtct.2023.03.022_bib0019","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtct.2022.04.008","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.03.022_bib0020","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1182\/bloodadvances.2022007676","article-title":"The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes","volume":"6","author":"Faruqi","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.03.022_bib0021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood.2022017866","article-title":"Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy","volume":"141","author":"Newman","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.03.022_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013A metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.jtct.2023.03.022_bib0023","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1055\/s-0040-1721416","article-title":"Prevalence and neighborhood geomapping of COVID-19 in an underserved Chicago pregnant population","volume":"10","author":"Buhimschi","year":"2020","journal-title":"AJP Rep"},{"key":"10.1016\/j.jtct.2023.03.022_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200107123450205","article-title":"Neighborhood of residence and incidence of coronary heart disease","volume":"345:","author":"Diez Roux","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.03.022_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11524-015-9959-y","article-title":"Constructing a time-invariant measure of the socio-economic status of U.S. census tracts","volume":"93","author":"Miles","year":"2016","journal-title":"J Urban Health"},{"key":"10.1016\/j.jtct.2023.03.022_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8161","article-title":"Enrollment of Black participants in pivotal clinical trials supporting US Food and Drug Administration approval of chimeric antigen receptor\u2013T cell therapy for hematological malignant neoplasms","volume":"5","author":"al Hadidi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2023.03.022_bib0027","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.23157","article-title":"Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review","volume":"112","author":"Ford","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0028","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.22436","article-title":"Provider roles in the recruitment of underrepresented populations to cancer clinical trials","volume":"109","author":"Howerton","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0029","doi-asserted-by":"crossref","first-page":"e28023","DOI":"10.1002\/pbc.28023","article-title":"Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics","volume":"67","author":"Russo","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.2021.0669","article-title":"Effect of postreinduction therapy consolidationwith blinatumomab vs chemotherapy on disease-free survival in children, adolescents, and young adults with first relapse of B-cell acute lymphoblastic leukemia: a randomized clinical trial","volume":"325","author":"Brown","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2023.03.022_bib0031","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1200\/JCO.2001.19.6.1728","article-title":"Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment","volume":"19","author":"Lara","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0032","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1200\/JCO.2005.03.8976","article-title":"Factors associated with participation in breast cancer treatment clinical trials","volume":"24","author":"Avis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0033","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.acap.2022.06.009","article-title":"Time spent at well-child care visits for English- and Spanish-speaking parents","volume":"23","author":"Liljenquist","year":"2023","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.jtct.2023.03.022_bib0034","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.9038","article-title":"Assessment of factors associated with parental perceptions of voluntary decisions about child participation in leukemia clinical trials","volume":"4","author":"Aristizabal","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2023.03.022_bib0035","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/annonc\/mdu572","article-title":"Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis","volume":"26","author":"Petridou","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0036","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3747\/co.v15i4.260","article-title":"The economic impact on families when a child is diagnosed with cancer","volume":"15","author":"Miedema","year":"2008","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JOP.2014.001495","article-title":"Financial burden of pediatric cancer for patients and their families","volume":"11","author":"Warner","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jtct.2023.03.022_bib0038","first-page":"4747","article-title":"Understanding the financial and psychological impact of employment disruption among caregivers of pediatric HSCT recipients: a mixed methods analysis","volume":"30","author":"Biddell","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2023.03.022_bib0039","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1182\/bloodadvances.2022007197","article-title":"Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia","volume":"6","author":"Muffly","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.03.022_bib0040","unstructured":"Pharmacy Times (PTce). Optimizing the value of CAR T-cell therapy: managed care considerations from recent clinical findings [online activity]. August 16, 2021, to February 18, 2022. Available at:https:\/\/www.optimizing-the-value-of-car-t-cell-therapy-managed-care-considerations-from-recent-clinical-find. Accessed August 1, 2022."},{"key":"10.1016\/j.jtct.2023.03.022_bib0041","unstructured":"Novartis Pharmaceuticals Corp. KYMRIAH (tisagenlecleucel). Find an authorized treatment center. Available at: https:\/\/www.Us.Kymriah.Com\/Treatment-Center-Locator\/. Accessed August 1, 2022."},{"key":"10.1016\/j.jtct.2023.03.022_bib0042","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.annepidem.2020.01.012","article-title":"Neighborhood-level measures of socioeconomicstatus are more correlated with individual-level measures in urban areas compared with less urban areas","volume":"43","author":"Xie","year":"2020","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jtct.2023.03.022_bib0043","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1353\/hpu.2015.0122","article-title":"Concordance between individual vs area-level socioeconomic measures in an urban setting","volume":"26","author":"Narla","year":"2015","journal-title":"J Health Care Poor Underserved"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723011983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:08:24Z","timestamp":1763003304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723011983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2666636723011983"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to Chimeric Antigen Receptor T Cell Clinical Trials in Underrepresented Populations: A Multicenter Cohort Study of Pediatric and Young Adult Acute Lymphobastic Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}